$6.05
-0.220 (-3.51%)
At Close: Jul 31, 2026
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
07:30am, Thursday, 25'th Jul 2024
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach a
The Company's AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program The Company's AI-guided predictive targeting platform d
• 84% of Patients Arrive at Doctor Visits Underinformed • Underscores Growing Importance of HCP and DTC Alignment in Pharma Commercialization and Marketing Strategies• OPRX Closes First Combin
OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript
11:21pm, Tuesday, 14'th May 2024
OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2024 Earnings Conference Call May 14, 2024 2:30 PM ET Company Participants William Febbo - CEO Edward Stelmakh - CFO Steve Silvestro - President Andrew D'Silva
OptimizeRx Reports First Quarter 2024 Financial Results
04:01pm, Tuesday, 14'th May 2024
WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and
Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?
11:01am, Monday, 13'th May 2024
The consensus price target hints at a 34.8% upside potential for OptimizeRx (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estima
OptimizeRx to Participate in Upcoming Investor Conferences
04:30pm, Monday, 06'th May 2024
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach a
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
07:30am, Friday, 26'th Apr 2024
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling
After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)
10:36am, Tuesday, 23'rd Apr 2024
OptimizeRx (OPRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revisin
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)
10:36am, Monday, 22'nd Apr 2024
OptimizeRx (OPRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revisin
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
07:30am, Thursday, 18'th Apr 2024
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
07:00am, Tuesday, 16'th Apr 2024
WALTHAM, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
07:30am, Thursday, 11'th Apr 2024
WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and
7 Top Undervalued Stocks Primed for a Multibagger Recovery
06:00am, Saturday, 06'th Apr 2024
If you're looking for undervalued stocks, you don't have to look far, despite the rally. The past year or so has been a wild rollercoaster ride for investors.
OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript
11:20am, Thursday, 28'th Mar 2024
OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript
Sign In
Buy OPRX